Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Su

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Case Reports|July 23, 2020
Misdiagnosis of Bell's palsy: Case series and literature reviewColin Bacorn, Nancy Su Teng Fong, Lily Koo Lin
FEBS Letters|February 5, 2004
Functional silencing of hepatic microsomal glucose-6-phosphatase gene expression in vivo by adenovirus-mediated delivery of short hairpin RNAAlan Huang, Yan Chen, Xinzhong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2019
Discovery and optimization of covalent Bcl-xL antagonistsHerschel Mukherjee, Nancy Su, Matthew A Belmonte, et al.
Endocrine|October 5, 2024
Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experienceDavid Tak Wai Lui, Kimberly Hang Tsoi, Carol Ho Yi Fong, et al.
The Journal of Biological Chemistry|September 9, 2008
Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2Joseph M Gozgit, Geraldine Bebernitz, Pankaj Patil, et al.
Nature Chemical Biology|September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chainGizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
ACS Medicinal Chemistry Letters|April 16, 2025
Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel-Lindau Tumor Suppressor Protein (VHL)Simon C C Lucas, Yong Xu, Sarah Hewitt, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2007
Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer targetMalcolm S Buchanan, Anthony R Carroll, Gregory A Fechner, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Case Reports|July 23, 2020
Misdiagnosis of Bell's palsy: Case series and literature reviewColin Bacorn, Nancy Su Teng Fong, Lily Koo Lin
FEBS Letters|February 5, 2004
Functional silencing of hepatic microsomal glucose-6-phosphatase gene expression in vivo by adenovirus-mediated delivery of short hairpin RNAAlan Huang, Yan Chen, Xinzhong Wang, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2019
Discovery and optimization of covalent Bcl-xL antagonistsHerschel Mukherjee, Nancy Su, Matthew A Belmonte, et al.
Endocrine|October 5, 2024
Real-world efficacy and safety of naltrexone-bupropion therapy in Chinese patients with obesity: A single-centre experienceDavid Tak Wai Lui, Kimberly Hang Tsoi, Carol Ho Yi Fong, et al.
The Journal of Biological Chemistry|September 9, 2008
Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2Joseph M Gozgit, Geraldine Bebernitz, Pankaj Patil, et al.
Nature Chemical Biology|September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chainGizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
ACS Medicinal Chemistry Letters|April 16, 2025
Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel-Lindau Tumor Suppressor Protein (VHL)Simon C C Lucas, Yong Xu, Sarah Hewitt, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2007
Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer targetMalcolm S Buchanan, Anthony R Carroll, Gregory A Fechner, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
Pageof 3